mRNA indicates messenger RNA; Tdap, tetanus, diphtheria, pertussis.
aFor the first-dose mRNA COVID-19 cohort, n = 1 180 006. There were 45 patients (0.004%) with a new RVO diagnosis. For the second-dose mRNA COVID-19 cohort, n = 1 180 006. There were 93 patients (0.006%) with a new RVO diagnosis.
bFor the first-dose mRNA COVID-19 cohort, n = 1 470 351. There were 69 patients (0.005%) with a new RVO diagnosis. For the influenza cohort, n = 1 470 351. There were 20 patients (0.002%) with a new RVO diagnosis.
cFor the first-dose mRNA COVID-19 cohort, n = 718 400. There were 27 patients (0.004%) with a new RVO diagnosis. For the Tdap cohort, n = 718 400. There were 27 patients (0.004%) with a new RVO diagnosis.